Anders Ulvenstam

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

David Erlinge, Elmir Ömerovic, Ole Fröbert et al. · New England Journal of Medicine · 2017 · 285 citations · Full text

Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes

Christian Dworeck, Björn Redfors, Oskar Angerås et al. · JAMA Network Open · 2020 · 79 citations · Full text

Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Sebastian Völz, Björn Redfors, Oskar Angerås et al. · European Heart Journal · 2021 · 68 citations · Full text

Heart Failure, Multilevel Modelling, Swedish Coronary Angiography +22